Cargando…
Mitochondria Targeted Antioxidant Significantly Alleviates Preeclampsia Caused by 11β-HSD2 Dysfunction via OPA1 and MtDNA Maintenance
We have previously demonstrated that placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) dysfunction contributes to PE pathogenesis. We sought to elucidate molecular mechanisms underlying 11β-HSD2 dysfunction-induced PE and to seek potential therapeutic targets using a 11β-HSD2 dysfunction-...
Autores principales: | Long, Jing, Huang, Yan, Tang, Zhengshan, Shan, Yali, Feng, Dou, Wang, Wenqin, Liu, Juan, Huang, Ying, Gu, Hang, Guo, Dewei, Yao, Ruojin, Ni, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404992/ https://www.ncbi.nlm.nih.gov/pubmed/36009224 http://dx.doi.org/10.3390/antiox11081505 |
Ejemplares similares
-
OPA1 Mutation and Late-Onset Cardiomyopathy: Mitochondrial Dysfunction and mtDNA Instability
por: Chen, Le, et al.
Publicado: (2012) -
mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases
por: Shang, Dehao, et al.
Publicado: (2023) -
MtDNA-maintenance defects: syndromes and genes
por: Viscomi, Carlo, et al.
Publicado: (2017) -
miRNAs in mtDNA-less cell mitochondria
por: Dasgupta, N, et al.
Publicado: (2015) -
OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2010)